HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John M Skibber Selected Research

Indicators and Reagents (Reagents)

9/2014Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery.
5/2012Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John M Skibber Research Topics

Disease

43Rectal Neoplasms (Rectal Cancer)
12/2022 - 11/2002
31Neoplasms (Cancer)
01/2023 - 11/2002
12Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 03/2007
9Carcinoma (Carcinomatosis)
01/2023 - 01/2003
9Adenocarcinoma
11/2018 - 12/2006
8Colonic Neoplasms (Colon Cancer)
01/2021 - 03/2007
6Pathologic Complete Response
07/2017 - 09/2003
4Neoplasm Metastasis (Metastasis)
01/2023 - 02/2013
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 02/2007
2Lymphatic Metastasis
10/2019 - 02/2013
2Anus Neoplasms (Anal Cancer)
01/2018 - 01/2017
2Dehydration (Water Stress)
01/2018 - 02/2014
2Pain (Aches)
04/2011 - 11/2002
2Margins of Excision
06/2007 - 02/2006
1Microsatellite Instability
01/2021
1Stomach Neoplasms (Stomach Cancer)
11/2018
1Acute Kidney Injury (Acute Renal Failure)
01/2018
1Obesity
06/2017
1Wound Infection (Wound Infections)
01/2013
1Anal Canal Carcinoma
04/2010
1Wounds and Injuries (Trauma)
03/2010
1Pelvic Pain
11/2002
1Ganglioneuroma
06/2002

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2006
6Capecitabine (Xeloda)FDA Link
12/2019 - 11/2006
5Fluorouracil (Carac)FDA LinkGeneric
07/2017 - 01/2003
3Carcinoembryonic AntigenIBA
02/2013 - 02/2006
2Indicators and Reagents (Reagents)IBA
09/2014 - 05/2012
2Bevacizumab (Avastin)FDA Link
02/2014 - 03/2010
1CurcuminIBA
12/2022
1Biosimilar PharmaceuticalsIBA
01/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2019
1VemurafenibIBA
04/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2014
1Metformin (Glucophage)FDA LinkGeneric
02/2013
1Pyridinolcarbamate (P23)IBA
08/2011
1NF-kappa B (NF-kB)IBA
04/2010
1MucinsIBA
02/2010

Therapy/Procedure

20Radiotherapy
10/2022 - 09/2003
20Neoadjuvant Therapy
10/2022 - 11/2006
19Therapeutics
01/2023 - 06/2002
9Drug Therapy (Chemotherapy)
01/2017 - 09/2003
6Chemoradiotherapy
08/2017 - 12/2006
4Re-Irradiation
10/2018 - 05/2010
4Proctectomy
02/2013 - 02/2010
4Adjuvant Chemotherapy
01/2013 - 06/2006
3Ileostomy
01/2018 - 01/2013
3Aftercare (After-Treatment)
03/2013 - 11/2002
3Pelvic Exenteration
06/2007 - 11/2002
2Operative Time
01/2023 - 02/2013
2Operative Surgical Procedures
01/2020 - 07/2005
2Lymph Node Excision (Lymph Node Dissection)
10/2019 - 02/2012
2Colectomy
01/2015 - 09/2011
2Colostomy
03/2013 - 01/2013
1Gastrectomy
11/2018
1Cranial Irradiation
12/2017
1Combination Drug Therapy (Combination Chemotherapy)
01/2017
1Minimally Invasive Surgical Procedures
01/2015
1Continuity of Patient Care
07/2014
1Length of Stay
02/2013
1Hepatectomy
02/2013
1Adjuvant Chemoradiotherapy
06/2007
1Salvage Therapy
07/2005
1Pain Management
11/2002